volume (ECF) were measured in the supine position and after 3 hours upright posture (PRA and NE) There are few reports of transplacental Li intoxication none of which describe renal manifestations, although this is well documented in adults. We studied a 3510 gm male neonate born at 35 weeks gestation to a 38 year old woman who ingested 1.8 gm/da of Li carbonate throughout her pregnancy. Polyhydraminos was noted at delivery. At birth the serum Li concentration was 1.0 mEq/L. By the second day the urinary output exceeded 6.4 ml/kg/ hr; polyuria persisted even after serum Li concentration fell to zero at four days of age. Ccr was normal ( 4 . 8 ml/min). Serum and urinary osmolalities were 294 and 100 mOsm/kg respectively; urea provided 17% of the total urinary solute. At 5 days of age the child was subjected to a vasopressin test (50 mU/kg, I.V.). This resulted in an increase in Uosm from 87 to 156 mOsm/kg and a slight decrease in plasma osmolality from 293 to 287 mOsm/kg; , urea accounted for 6.1% of the urinary solute. Cyclic AMP excretion rose from 0.25 before to 0.75 nM/min after vasopressin. A similar response was encountered at one month of age. By 2 months, Uosm rose to 597 mOsm/kg following 6 hours of water deprivation. These data indicate that Li intoxication results in similar but longer lasting effects on the kidney of the newborn than that of the adult. The duration of the concentrating defect may be due to enhanced sensitivity of the newborn tubule to Li or to interference with the development of the renal concentrating mechanisms. These data suggest that significant CRH occurs in utero by both cell proliferation and an increase in cell s i z e r a a s i g n i f icant increase in renal function parallels CRH in the fetus. According to earlier reports albuminuria is accompanied by an increased excretion of zinc and corticosteroid treatment causesa precipitous fall in serum zinc level. These questions were examined in 92 children with nephrotic syndrome and in 33 controls in whom zinc studies were performed at time of initial diagnosis, during Prednisone treatment and after treatment was terminated. The plasma zinc content was low in all children with active nephrosis, mean 51.7 pg/100 ml, with values as low as 22 ug/100mL A slow increase was observed with improvement of the disease. It remained low, however, even in cases of complete and long-lastin remission (69 vg/100 ml) .
For all groups the quantitative zinc excretion was not significantly different from the controls except for patients undewing massive diuresis and those in long-lasting remission. During the polyuric phase our patients excreted up to 2500 pg zinc/24 hrs (mean 1770 ug/24 hrs). The zinc excretion of patients in remission was twice the control value (mean 860 ug/24 hrs). The correlation between plasma and urinary zinc and total protein. albumin and a2-globulin concentrations was studied also. The hair zinc level was low in all cases of nephrotic syndrome.
A significant urinary zinc loss is not observed in nephrotic syndrome. The low plasma zinc level is not caused by eicher zinc excretion or corticosteroid administration and can not be explained by changes in serum protein or its fractions. Additional pactors will have to be investigated.
